The evolution of Raynaud's phenomenon: a longterm prospective study

Area of Science:

• Rheumatology
• Immunology
• Dermatology

Background:

• Raynaud's phenomenon (RP) can indicate underlying connective tissue disease (CTD).
• Early identification of patients at risk for CTD progression is crucial for timely intervention.
• Predicting the evolution of secondary RP requires understanding key clinical and laboratory markers.

Purpose of the Study:

• To prospectively evaluate patients with suspected secondary RP.
• To determine the prognosis and identify predictors of CTD development in this cohort.
• To establish a risk factor model for CTD evolution.

Main Methods:

• Prospective cohort study of 64 patients with suspected secondary RP.
• Evaluations included history, examination, imaging, pulmonary function tests, serological markers (antinuclear and anticentromere antibodies - ACA), and nailfold capillary microscopy (NCM).
• Logistic regression analysis was employed to identify predictors and develop a risk model.

Main Results:

• 50% of patients progressed to a definite CTD over 8.4 years.
• Baseline nailfold capillary abnormalities (OR=8.3) predicted the development of any definite CTD.
• Abnormal nailfold capillaries (OR=21.8) and hand swelling (OR=18.5) predicted systemic sclerosis; positive ACA predicted CREST syndrome (OR=22.5).

Conclusions:

• Half of patients with suspected secondary RP will develop a CTD.
• Nailfold capillary microscopy is a valuable tool for predicting the development of systemic sclerosis and other CTDs.
• NCM should be integrated into the initial evaluation of patients presenting with secondary RP.